Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Velasof 400 mg/100 mg (Sofosbuvir and Velpatasvir) is an antiviral medication manufactured by Hetero Healthcare Ltd. used to treat chronic Hepatitis C. It inhibits viral replication and is highly effective across multiple HCV genotypes.
| Main Ingredients | Sofosbuvir (400 mg) & Velpatasvir (100 mg) |
| Strength | 400 + 100 mg |
| Drug Class | Direct-Acting Antiviral (DAA) Agent |
| Primary Indications | Chronic Hepatitis C (HCV) Infection |
| Storage | Dry storage, room temperature between 20°C to 25°C |
| Packaging | Typically 28 tablets per bottle |